Chemoinformaics analysis of (6r)-tricyclo[5.2.1.02,6]decan-8-one
| Molecular Weight | 150.221 | nRot | 0 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 13 |
| Exact Molecular Weight | 150.104 | nRing | 3 |
| Solubility: LogS | -2.52 | nHRing | 0 |
| Solubility: LogP | 2.167 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 26.8371 |
| nHD | 0 | BPOL | 14.9129 |
| QED | 0.516 |
| Synth | 4.427 |
| Natural Product Likeliness | 1.845 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.007 |
| CACO-2 | -4.588 |
| MDCK | 0.0000418 |
| BBB | 0.967 |
| PPB | 0.628908 |
| VDSS | 1.158 |
| FU | 0.308615 |
| CYP1A2-inh | 0.327 |
| CYP1A2-sub | 0.894 |
| CYP2c19-inh | 0.149 |
| CYP2c19-sub | 0.837 |
| CYP2c9-inh | 0.151 |
| CYP2c9-sub | 0.821 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.749 |
| CYP3a4-inh | 0.11 |
| CYP3a4-sub | 0.374 |
| CL | 17.514 |
| T12 | 0.647 |
| hERG | 0.02 |
| Ames | 0.018 |
| ROA | 0.077 |
| SkinSen | 0.149 |
| Carcinogencity | 0.325 |
| EI | 0.908 |
| Respiratory | 0.216 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.928547 |